MarketPeel
Insider Trading Intelligence
LC

Lily Cheung

PLRX
CHIEF HUMAN RESOURCE OFFICER · PLIANT THERAPEUTICS, INC. · CIK 0001962207
FILING MIX · LIFETIME64%/36%
BUYS
9
SELLS
5
TOTAL VALUE
$51.5K
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
123,000
AVG SELL PX
$4.57
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Lily Cheung, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-1.68%+2.19%-3.88%-3.88%
14d2+100.00%-4.79%+1.24%-6.02%-6.02%
30d2+50.00%-35.66%+1.52%-37.18%-37.18%
60d2+50.00%-42.07%-5.20%-36.87%-36.87%
90d2+50.00%-43.10%-3.52%-39.57%-39.57%
180d2(1 pending)+100.00%-88.05%+4.77%-92.82%-92.82%
1y2(1 pending)+100.00%-88.49%+16.09%-104.58%-104.58%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLRX · 123,000 shares · as of Apr 17, 2026
075,000150,000225,000300,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 5 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Human Resource Officer
51,7500Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,75051,750Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
52,00052,000Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Human Resource Officer
52,0000Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Human Resource Officer
123,0000Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
123,000123,000Apr 17, 2026Apr 17, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
300,000300,000Jan 22, 2026Jan 26, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,534$1.28$9.6K44,847Jan 20, 2026Jan 22, 2026View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,87550,425Jan 23, 2025Jan 27, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,75051,750Jan 23, 2025Jan 27, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,740$11.20$41.9K24,550Jan 17, 2025Jan 22, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,00026,795Jan 23, 2024Jan 24, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
52,00052,000Jan 23, 2024Jan 24, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
123,000123,000Jan 19, 2023Jan 23, 2023View →
Other insiders · PLRX
Loading peer insiders…
About this filer
CIK 0001962207
ROLE
Chief Human Resource Officer
PRIMARY
PLRX
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001962207DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback